The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study.

导出 OA

翻译打印收藏纠错

作者： Yoo-Young,Lee ^[1] ; Soyoun Rachel,Kim ^[2] ; Alexandra,Kollara ^[3] ; Theodore,Brown ^[3] ; Taymaa,May ^[4]

作者单位： Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea. ^[1] Division of Gynecologic Oncology, Princess Margaret Cancer Center, Toronto, ON, Canada. ^[2] Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. ^[3] Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada. ^[4] Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada. taymaa.may@uhn.ca. ^[5]

关键词 Cytoreductive Surgery Epithelial Ovarian Cancer Large Bowel Resection Progression-Free Survival Survival Time

主题词人类(Humans);女(雌)性(Female);回顾性研究(Retrospective Studies);化学疗法, 辅助(Chemotherapy, Adjuvant);卵巢肿瘤(Ovarian Neoplasms);肿瘤辅助疗法(Neoadjuvant Therapy)

DOI 10.3802/jgo.2022.33.e76

PMID 36047378

发布时间 2022-12-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交